Tentative Program
as of June 1, 2026
Day 1 (Sunday, June 28, 2026)
| Time | Session | Speakers | Chairpersons |
|---|---|---|---|
| 16:00-16:10 | Welcome Address |
Toshikazu Ushijima
(Hoshi University, Japan) Lillian L. Siu (Princess Margaret Cancer Centre, Canada) |
|
| 16:10-16:40 | Opening Keynote Lecture (I): Epigenetic Field Carcinogenesis and Precision Risk Estimation | Toshikazu Ushijima (Hoshi University, Japan) | Lillian L. Siu |
| 16:40-17:10 | Opening Keynote Lecture (II): Precision Oncology in Head and Neck Cancers: From Molecular Insights to Global Impact | Lillian L. Siu (Princess Margaret Cancer Centre, Canada) | Toshikazu Ushijima |
| 17:10-18:00 | Young Investigator Highlights |
Daniel Faden
(Mass General Brigham, US) Takao Fujisawa (National Cancer Center, Japan) |
Ken Kato Quynh-Thu Le |
| 18:30-20:30 | Welcome Reception | ||
Day 2 (Monday, June 29, 2026)
| Time | Session | Speakers | Chairpersons |
|---|---|---|---|
| 08:30-10:00 | Session 1: Gastric Cancer |
Masanobu Oshima
(Kanazawa University, Japan) Patrick Tan (Duke-NUS Medical School, Singapore) Shumpei Ishikawa (The University of Tokyo, Japan) |
Atsushi Kaneda Yoshiaki Ito(National University of Singapore, Singapore) |
| 10:00-10:15 | Coffee Break | ||
| 10:15 - 11:15 | Session 2: Liquid Biopsy and Minimal Residual Disease Monitoring |
Hideaki Bando
(National Cancer Center, Japan) Dennis Lo (The Chinese University of Hong Kong, Hong Kong) |
Katsuya Tsuchihara
(National Cancer Center, Japan) Patrick Tan |
| 11:15-12:00 | Session 3: Short Talks |
Dechan Lin(University of Southern California, US) Naoko Iida(National Cancer Center, Japan) Mitsugu Fujita(Kindai University, Japan) |
Yasuhiro Yamada (The University of Tokyo, Japan) Masanobu Oshima |
| 12:00-12:10 | Break | 12:10-13:00 | Luncheon Seminar: New Frontiers in Precision Medicine Enabled by Liquid Biopsy: ctDNA-Guided Therapeutics for HER2-Amplified Tumours Sponsored by Guardant Health, Inc |
Yoshiaki Nakamura (University of Oxford, UK) | Hideaki Bando |
| 13:00-13:10 | Break | ||
| 13:10-14:40 | Session 4: Esophageal Cancer |
Manabu Muto
(Kyoto University, Japan) Suet Yi Leung (The University of Hong Kong, Hong Kong) Hidewaki Nakagawa (RIKEN Center for Integrative Medical Sciences, Japan) |
Manabu Muto Suet Yi Leung |
| 14:40-15:00 | Coffee Break | ||
| 15:00-16:30 | Session 5: Head and Neck Cancer |
Mizuo Ando
(Okayama University, Japan) Kevin J. Harrington (The Institute of Cancer Research, UK) Takahiro Tsujikawa (Kyoto Prefectural University of Medicine, Japan) |
Toshinori Ando
(Hiroshima University, Japan) Kevin J. Harrington |
| 16:30-16:45 | Break | ||
| 16:45-17:45 | Poter Presentations | ||
| 18:00-20:00 | Conference Dinner | ||
Day 3 (Tuesday, June 30, 2026)
| Time | Session | Speakers | Chairpersons |
|---|---|---|---|
| 08:30-10:00 | Session 6: Viral and Bacterial Oncogenesis for Therapeutic Implications |
Atsushi Kaneda
(Chiba University, Japan) Jun Yu (The Chinese University of Hong Kong, Hong Kong) Noah Sasa (The University of Osaka, Japan) |
Hidewaki Nakagawa Hiroyuki Takamaru (National Cancer Center, Japan) |
| 10:00-10:15 | Coffee Break | ||
| 10:15-11:15 | Session 7: Precision Radiotherapy and Phototherapy |
Ryuhei Okada
(Institute of Science Tokyo, Japan) Quynh-Thu Le (Stanford University, US) |
Kazuaki Chikamatsu
(Gunma University, Japan) Masanobu Abe (Cancer Institute Hospital of JFCR, Japan) |
| 11:15-12:30 | Break | ||
| 12:30-14:30 | Session 8: Immunotherapy and Other Immune-related Therapies in Upper Aerodigestive Cancer |
Ken Kato
(National Cancer Center, Japan) Danny Rischin (Peter MacCallum Cancer Centre, Australia) Yosuke Togashi (Okayama University, Japan) Pinaki Bose (University of Calgary, Canada) |
Yosuke Togashi Danny Rischin |
| 14:30-14:50 | Coffee Break | ||
| 14:50-16:20 | Session 9: Next-Generation Therapeutics: ADCs, Bi-/Tri-specifics, Degraders |
Kyoko Hida
(Hokkaido University, Japan) Daniel S.W. Tan (National Cancer Centre, Singapore) Toshio Shimizu (Kansai Medical University Hospital, Japan) |
Toshio Shimizu Daniel S.W. Tan |
| 16:20-16:35 | Closing Remarks |
Lillian L. Siu
(Princess Margaret Cancer Centre, Canada) Mizuo Ando (Okayama University, Japan) |
|